more

Masimo (MASI)

(Real Time Quote from BATS)

$105.77 USD

-2.32 (-2.15%)

Updated Jul 30, 2024 01:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	24.03%
2	Buy	17.70%
3	Hold	9.37%
4	Sell	5.03%
5	Strong Sell	2.48%
S&P	500	11.19%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5 2

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth D Momentum C VGM

Industry Rank:

Top 42% (105 out of 251)

Industry: Medical - Instruments

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Masimo (MASI) Earnings and Revenues Beat Estimates in Q2

by Zacks Equity Research Published on July 29,2020

Masimo (MASI) continues to gain from key Product segment, which witnessed solid growth in Q2.

medical

Masimo (MASI) Surpasses Q2 Earnings and Revenue Estimates

by Zacks Equity Research Published on July 28,2020

Masimo (MASI) delivered earnings and revenue surprises of 8.97% and 4.02%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

MASINegative Net Change

Masimo (MASI) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research Published on July 21,2020

Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MASINegative Net Change

Masimo (MASI) Introduces Automation and Connectivity Solution

by Zacks Equity Research Published on July 15,2020

Masimo's (MASI) UniView: 60 leverages the Masimo Hospital Automation platform to boost clinical workflows.

medical

4 Telehealth Stocks to Gain on Virtual Response to Coronavirus

by Sreoshi Bera Published on July 13,2020

Advancement in technology has helped cater to the growing medical demand during the coronavirus pandemic. Here are four telehealth stocks set to boom.

medical

Masimo's New Solution to Reduce Opioid Withdrawal Symptoms

by Zacks Equity Research Published on July 01,2020

Masimo's (MASI) new solution can help reduce symptoms associated with opioid withdrawal, thereby helping OUD patients with their treatment.

medical

Masimo's (MASI) New Offering to Improve Patient Outcomes

by Zacks Equity Research Published on June 29,2020

Masimo's (MASI) Centroid gets FDA clearance and can help clinicians monitor patient position, thereby improving patient outcomes.

medical

Remote Patient Monitoring Gains Prominence: 3 Stocks to Watch

by Trina Mukherjee Published on June 26,2020

Let's keep a watch on three stocks that are committed toward enhancing and offering RPM to fight against coronavirus.

medical

Masimo (MASI) Boosts Product Portfolio with New Solution

by Zacks Equity Research Published on June 24,2020

Masimo (MASI) unveils Masimo Sleep to help consumers better understand their quality of sleep.

medical

Masimo Launches Masimo SafetyNet-Open to Fight Coronavirus

by Zacks Equity Research Published on June 22,2020

Masimo's (MASI) newly-launched SafetyNet-Open has been developed to ensure health and safety during the coronavirus outbreak.

medical

3 Digital HealthCare Stocks in the Spotlight Amid Coronavirus

by Sriparna Ghosal Published on June 18,2020

In the face of the pandemic, the digital health management space continues to thrive on a number of positive developments.

medical

Masimo (MASI) Gains But Lags Market: What You Should Know

by Zacks Equity Research Published on June 05,2020

Masimo (MASI) closed the most recent trading day at $220.24, moving +0.75% from the previous trading session.

MASINegative Net Change

Why Is Masimo (MASI) Up 5.3% Since Last Earnings Report?

by Zacks Equity Research Published on May 28,2020

Masimo (MASI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

MASINegative Net Change

Here's Why You Should Retain Masimo Stock (MASI) For Now

by Zacks Equity Research Published on May 18,2020

Investor confidence remains high in Masimo (MASI) stock, thanks to solid prospects.

Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)?

by Zacks Equity Research Published on May 11,2020

Sector ETF report for PTH

Masimo (MASI) Q1 Earnings Beat Estimates, Margins Expand

by Zacks Equity Research Published on April 29,2020

Masimo (MASI) sees solid growth in key Product segment in Q1.

Masimo Collaborates With Samsung to Help Fight Coronavirus

by Zacks Equity Research Published on April 20,2020

Masimo (MASI) and Samsung Electronics America collaborate to bring Masimo SafetyNet Patient App on the latter's select smartphones for faster distribution of Masimo SafetyNet to COVID-19 patients.